JP2021001183A5 - - Google Patents

Download PDF

Info

Publication number
JP2021001183A5
JP2021001183A5 JP2020151001A JP2020151001A JP2021001183A5 JP 2021001183 A5 JP2021001183 A5 JP 2021001183A5 JP 2020151001 A JP2020151001 A JP 2020151001A JP 2020151001 A JP2020151001 A JP 2020151001A JP 2021001183 A5 JP2021001183 A5 JP 2021001183A5
Authority
JP
Japan
Prior art keywords
calendula
hasa
bryonia
potency
calendula calendula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020151001A
Other languages
English (en)
Other versions
JP6961055B2 (ja
JP2021001183A (ja
Filing date
Publication date
Priority claimed from JP2017217177A external-priority patent/JP2018048195A/ja
Application filed filed Critical
Publication of JP2021001183A publication Critical patent/JP2021001183A/ja
Publication of JP2021001183A5 publication Critical patent/JP2021001183A5/ja
Priority to JP2021167177A priority Critical patent/JP2022009021A/ja
Application granted granted Critical
Publication of JP6961055B2 publication Critical patent/JP6961055B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (8)

  1. 親水性ホメオパシー性水性有効物質(HASA)−ゲルマトリックスを製造する方法であって、以下の工程:
    (a)アルニカ・モンタナ(Arnica montana)およびリーダム・パルストレ(Ledum palustre)を含むホメオパシー化合物を、無抑制の水性組成物と組み合わせて、少なくとも30CのポテンシーのHASAを製造し;
    (b)該HASAを少なくとも1種類の親水性ゲル化剤と組み合わせ;そして
    (c)その後、架橋剤の少なくとも1種類および/または一つの重合剤を使用して親水性HASA−ゲルマトリックスを形成すること;
    を含む、前記方法。
  2. HASAが少なくとも400Cのポテンシーを有する、請求項1に記載の方法
  3. HASAが少なくとも1Mのポテンシーを有する、請求項1に記載の方法
  4. HASAが少なくとも10Mのポテンシーを有する、請求項1に記載の方法
  5. 親水性HASA−ゲルマトリックスが少なくとも41%のHASAを含む、請求項1に記載の方法。
  6. 架橋剤が温度、圧力、pHにおける変化、放射、化学的架橋剤の少なくとも1種類を含む、請求項1に記載の方法。
  7. 放射が紫外線、ガンマ放射、または電子ビーム放射である、請求項6に記載の方法。
  8. ホメオパシー化合物が、ベリス・ペレンニス(Bellis perennis)、カルカレア・フォスフォリカ(Calcarea phosphorica)、カレンデュラ(Calendula)、ハイペリカム・パーフォラタム(Hypericum perforatum)ルース・トキシコデンドロン(Rhus toxicodendron)、ミレフォリウム(Millefolium)、ルタ・グラベオレンス(Ruta graveolens)、シムフィツム・オフィキナーレ(Symphytum officinale)、エイピス・メル(Apis Mel)、カンタリス(Cantharis)、アルティカリア・ウレンス(Urticartia Urens)、ベラドンナ(Belladonna)、フェラム・メタリカム(Ferrum Metallicum)、スタファサグリア(Staphasagria)、ヘパー・スルフリカム(Hepar Sulphericum)、ユーパトリウム・ペルフォリアタム(Euphatorium perfoliatum)、ブリオニア(Bryonia)、ナトラム・スルフリカム(Naturm Sulphericum)、カルカレア・カルボニカ(Calcarea carbonica)、およびハマメリス(Hamamelis)の少なくとも1種類をさらに含む、請求項1に記載の方法
JP2020151001A 2011-03-03 2020-09-09 ホメオパシー的療法的方法および組成物 Active JP6961055B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021167177A JP2022009021A (ja) 2011-03-03 2021-10-12 ホメオパシー的療法的方法および組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161448913P 2011-03-03 2011-03-03
US61/448,913 2011-03-03
US201161451385P 2011-03-10 2011-03-10
US61/451,385 2011-03-10
JP2017217177A JP2018048195A (ja) 2011-03-03 2017-11-10 ホメオパシー的療法的方法および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017217177A Division JP2018048195A (ja) 2011-03-03 2017-11-10 ホメオパシー的療法的方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021167177A Division JP2022009021A (ja) 2011-03-03 2021-10-12 ホメオパシー的療法的方法および組成物

Publications (3)

Publication Number Publication Date
JP2021001183A JP2021001183A (ja) 2021-01-07
JP2021001183A5 true JP2021001183A5 (ja) 2021-02-25
JP6961055B2 JP6961055B2 (ja) 2021-11-05

Family

ID=46753428

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013556651A Active JP6495572B2 (ja) 2011-03-03 2012-03-02 ホメオパシー的療法的方法および組成物
JP2017217177A Pending JP2018048195A (ja) 2011-03-03 2017-11-10 ホメオパシー的療法的方法および組成物
JP2020151001A Active JP6961055B2 (ja) 2011-03-03 2020-09-09 ホメオパシー的療法的方法および組成物
JP2021167177A Withdrawn JP2022009021A (ja) 2011-03-03 2021-10-12 ホメオパシー的療法的方法および組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2013556651A Active JP6495572B2 (ja) 2011-03-03 2012-03-02 ホメオパシー的療法的方法および組成物
JP2017217177A Pending JP2018048195A (ja) 2011-03-03 2017-11-10 ホメオパシー的療法的方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021167177A Withdrawn JP2022009021A (ja) 2011-03-03 2021-10-12 ホメオパシー的療法的方法および組成物

Country Status (9)

Country Link
US (2) US20120225018A1 (ja)
EP (2) EP2680869A4 (ja)
JP (4) JP6495572B2 (ja)
CN (2) CN103930119A (ja)
AU (4) AU2012223195A1 (ja)
BR (1) BR112013022530A2 (ja)
CA (1) CA2828883C (ja)
HK (1) HK1243637A1 (ja)
WO (1) WO2012119102A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2828883C (en) * 2011-03-03 2021-09-14 Nancy Josephine Polich Homeopathic therapeutic method and compositions
WO2018017813A1 (en) * 2016-07-20 2018-01-25 Polich Nancy Josephine High potency homeopathic gel formulation
CN107149611B (zh) * 2017-03-24 2020-10-09 王青虎 一种蒙药鼻炎喷雾剂及其制备方法
CN107468840B (zh) * 2017-08-17 2021-05-18 杭州仁德医药有限公司 一种活血止痛的外用贴膏

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438091A (en) 1943-09-06 1948-03-16 American Cyanamid Co Aspartic acid esters and their preparation
US2528378A (en) 1947-09-20 1950-10-31 John J Mccabe Jr Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
US2658072A (en) 1951-05-17 1953-11-03 Monsanto Chemicals Process of preparing amine sulfonates and products obtained thereof
US3155591A (en) 1961-12-06 1964-11-03 Witco Chemical Corp Hair rinse compostions of polyoxypropylene quaternary ammonium compounds
US3959461A (en) 1974-05-28 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Hair cream rinse formulations containing quaternary ammonium salts
US3929678A (en) 1974-08-01 1975-12-30 Procter & Gamble Detergent composition having enhanced particulate soil removal performance
US4387090A (en) 1980-12-22 1983-06-07 The Procter & Gamble Company Hair conditioning compositions
US4646730A (en) * 1986-05-23 1987-03-03 Johnson & Johnson Products, Inc. Color stabilized hydrogel dressing and process
US5106609A (en) 1990-05-01 1992-04-21 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
IT1261849B (it) * 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
CN1086939C (zh) 1995-10-16 2002-07-03 普罗克特和甘保尔公司 含有聚亚烷基二醇的调理香波
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
JP3913926B2 (ja) * 1999-04-14 2007-05-09 積水化成品工業株式会社 生体用粘着ゲルシートとその製造方法、それを用いた化粧品および医薬部外品
JP3460969B2 (ja) * 1999-10-08 2003-10-27 カネボウ株式会社 生体用粘着ゲルシート
JP2002020273A (ja) * 2000-07-06 2002-01-23 Saitama Daiichi Seiyaku Kk 馬用冷却シート
JP3875005B2 (ja) * 2000-08-18 2007-01-31 株式会社カネボウ化粧品 アフターサン用シート
AU2000276877A1 (en) * 2000-10-16 2002-04-29 Kanebo Limited Process for producing gel sheet for application to living body, gel sheet for application to living body obtained by the production process, and method of skin care with the same
JP4519408B2 (ja) * 2003-01-30 2010-08-04 ライオン株式会社 貼付剤組成及びその製造方法
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
US7229648B2 (en) * 2003-03-14 2007-06-12 Dreyer Lee R Homeopathic formulations useful for treating pain and/or inflammation
US20040242770A1 (en) * 2003-04-16 2004-12-02 Feldstein Mikhail M. Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith
JP2005160890A (ja) * 2003-12-05 2005-06-23 Toyo Ink Mfg Co Ltd 生体用粘着ゲルシート
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US8999401B2 (en) 2007-05-09 2015-04-07 Henry Steven Luria Delivery system and method to deliver homeopathic complexes comprising homeopathic colored pigment products for cosmetic use
KR20110056305A (ko) * 2008-08-29 2011-05-26 낸시 조세핀 폴리치 동종요법성 치료학적 방법
CA2828883C (en) * 2011-03-03 2021-09-14 Nancy Josephine Polich Homeopathic therapeutic method and compositions

Similar Documents

Publication Publication Date Title
JP2021001183A5 (ja)
JP2022009021A5 (ja)
JP2004532257A (ja) 高水溶性薬剤のテイスト・マスキング
SE7607462L (sv) Forfarande for behandling av avfall
Mishra et al. Effect of biologically synthesized silver nanoparticles on human cancer cells
BRPI0409345A (pt) sistema de liberação, pelìcula de sistema de liberação, e, processo para preparar o sistema de pelìcula de gel homogêneo
AR019031A1 (es) Forma farmaceutica de dosificacion de efavirenz en capsula o tableta comprimida y metodo para su preparacion
RU2008152402A (ru) Композиции, обладающие сильным противовирусным действием
CN106074406A (zh) 一种富马酸沃诺拉赞分散片及其制备方法
JP2008500287A5 (ja)
JP2014515728A5 (ja)
Jokanović et al. Synthesis and Properties of a New Dental Material Based on Nano‐Structured Highly Active Calcium Silicates and Calcium Carbonates
CN105030723B (zh) 一种淀粉胶囊及其制备方法
CN104906062B (zh) 一种索非布韦的片剂及其制备方法
Dorairaj et al. Green synthesis and characterization of UKMRC-8 rice husk-derived mesoporous silica nanoparticle for agricultural application
Khateeb et al. Ethno-veterinary practices used for the treatment of animal diseases in Doda district, Jammu & Kashmir
JP2013542985A5 (ja)
Murugan et al. Synthesis and characterization of Hydroxyapatite/Silver nanoparticles composites and their Antibacterial properties for Dental Filling Application
CN107496362A (zh) 一种富马酸沃诺拉赞固体分散体及其制备方法
JP2004051930A (ja) シリコーン撥水被覆の解除方法
CN104473891A (zh) 一种核黄素胃漂浮片及其制备方法
JPWO2021133886A5 (ja)
Atif et al. Homeopathic remedies to heal afflicted persons: a systematic review
Papp et al. Ethnomedicinal treatment of gastrointestinal disorders in Transylvania, Romania
Nyandoro et al. Biogenic synthesis of metal nanoparticles: promoting green nanotechnology and sustainable development goals